Polymorphisms of the 5' leader cistron of the human β2-adrenergic receptor regulate receptor expression

Journal of Clinical Investigation

Volumn 102, Issue 11, 1998, Pages 1927-1932

  McGraw, Dennis W ^a   Forbes, Susan L ^a   Kramer, Lisa A ^a   Liggett, Stephen B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Catecholamines; G protein coupled receptors; Mutations; Translation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CISTRON; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA TRANSLATION; TRANSLATION REGULATION;

EID: 0032442150     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4862     Document Type: Article

References (27)

1. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell. Mol. Biol. 8:334-339.
2. 2-adrenergic receptor polymorphisms. News Physiol. Sci. 10:265-273.
3. Green, S., J. Turki, M. Innis, and S.B. Liggett. 1994. Amino-terminal polymorphisms of the human β radrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 33:9414-9419.
4. 2-adrenergic receptor within the fourth trans-membrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268:23116-23121.
5. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. 13:25-33.
6. 2-adrenergic receptor polymorphisms: relevance to receptor function and asthmatic phenotypes. In The Genetics of Asthma. S.B. Liggett and D.A. Meyers, editors. Marcel Dekker, New York. 455-478.
7. 2-adrenergic receptor in nocturnal and non-nocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J. Clin. Invest. 95:1635-1641.
8. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet. 345:1213-1214.
9. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J. Clin. Invest. 100:3184-3188.
10. 2 adrenoceptor polymorphism is associated with elevated immunoglobulin E levels in asthmatic families. J. Allergy Clin. Immunol. 100:261-265.
11. Tan, S., I.P. Hall, J. Dewar, E. Dow, and B. Lipworth. 1997. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet. 350:995-999.
12. 2-adrenergic receptor: a protein with multiple membrane spanning domains and a chromosomal location shared with PDGF receptor gene. Proc. Natl. Acad. Sci. USA. 84:46-50.
13. 2-adrenergic receptor and their promoter regions. J. Biol. Chem. 262:7321-7327.
14. Parola, A.L., and B.K. Kobilka. 1994. The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J. Biol. Chem. 269:4497-4505.
15. Jones, A.S. 1963. Use of alkyltrimethylammonium bromide for the isolation of ribo- and deoxyribo-nucleic acid. Nature. 199:280-282.
16. 2 adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am. J. Respir. Crit. Care Med. 158:787-791.
17. 2-adrenergic receptor. Cell Signal. 10:197-204.
18. 2-adrenergic receptor. J. Biol. Chem. 272:7338-7343.
19. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
20. Calnan, B.J., B. Tidor, S. Biancalana, D. Hudson, and A.D. Frankel. 1991. Arginine-mediated RNA recognition: the arginine fork. Science. 252: 1167-1171.
21. Fedyk, E.R., A.A. Looney, and R.P. Phipps. 1996. Regulation of IgE and cytokine production by cAMP: implications for extrinsic asthma. Clin. Immunol. Immunopathol. 81:101-113.
22. Themmen, A.P.N., J.W.M. Martens, and H.G. Brunner. 1997. Gonadotropin receptor mutations. J. Endocrinol. 153:179-183.
23. Chattopadhyay, N., A. Mithat, and E.M. Brown. 1996. The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr. Rev. 17:289-307.
24. Rosenthal, W., A. Antaramian, S. Gilbert, and M. Birnbaumer. 1993. Nephrogenic diabetes insipidus: a V2 vasopressin receptor unable to stimulate adenylyl cyclase. J. Biol. Chem. 268:13030-13033.
25. 2 adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J. Clin. Invest. 102:1534-1539.
26. Kotanko, P., A. Binder, J. Tasker, P. DeFreitas, S. Kamdar, A.J. Clark, F. Skrabal, and M. Caulfield. 1997. Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. Hypertension. 30:773-776.
27. Large, V., L. Hellstrom, S. Reynisdottir, F. Lonnqvist, P. Eriksson, L. Lannfelt, and P. Arner. 1997. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J. Clin. Invest. 100:3005-3013.